Dr Reddy’s Strikes $67m Deal With Alvotech On Denosumab

Indian Firm Gains Rights In US And Europe; Builds Infrastructure For Biosimilars Unit

 
• By David Wallace
  
Handshake
Alvotech and Dr Reddy’s are collaborating on denosumab in the US and Europe
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business